INTRODUCTION
Certain primitive cell systems, such as cellular slime molds, exist either in a unicellular vegetative form or a differentiated form in which they become adhesive and aggregate into a multicellular structure. When the cells become adhesive, they synthesize surface polyvalent carbohydrate-binding proteins or lectins that mediate cell-to-cell adhesion (1) . Cell adhesion in the slime mold takes place via interaction of carbohydrate binding sites of the cell surface lectin with high affinity membrane glycoprotein (GP)' receptors. The initial interaction of one lectin binding site with one receptor oligosaccharide and then binding at multiple sites leads to rapid and stable cell cohesion (1) . Recent studies suggest that human platelets may recapitulate some of these primitive cellular responses during the process of thrombin-induced aggregation. Platelets activated by thrombin develop membrane bound lectin activity that appears to be important in platelet aggregation (2) . Gartner et al. (3) have shown that fibrinogen is the receptor for the endogenous lectin secreted by activated platelets. Thrombospondin (TSP) (4), also termed thrombin-sensitive protein (5) and glycoprotein G (6), is a major GP located in the a-granules of human platelets (7, 8) . It is secreted upon thrombin activation and binds to the platelet membrane in the presence of calcium (9) . Recent studies suggest that TSP is the endogenous lectin of human platelets (10) . In this paper, we present direct evidence demonstrating complex formation of fibrinogen with TSP.
METHODS
Materials. Lentil lectin (lens culinaris hemagglutinin), glucosamine, mannosamine, N-acetyl glucosamine, N Factor VIII antigen (VIII:AGN), and fibronectin as determined by lack of reactivity using monospecific antisera to these potential contaminants in an enzyme-linked immunosorbent assay (ELISA). The clottability of this fibrinogen was -96%. The protein migrated as a single band on 5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with an estimated M, of 330,000. The reduced protein in SDS-PAGE revealed a typical distribution of Aa-B,-, and -y-chains with absence of degradation products. When chromatographed on a Sepharose CL-6B column (1.5 X 45 cm) in 0.25 M NaCl, 0.05 M Tris-HCI, pH 8.6, fibrinogen eluted as a single sharp peak indicating freedom from detectable quantities of fibrin monomers (12) . TSP was isolated from thrombin-treated platelet supernate by Sepharose 4B gel exclusion chromatography followed by heparin-Sepharose affinity chromatography as described by Lawler et al. (4) . The TSP was >95% pure when analyzed by SDS-PAGE with an apparent Mr of 185,000 following reduction (9) (Fig. 1) . It was free of plasminogen, fibronectin, and Factor VIII:AGN by ELISA. Platelet membrane GPIIb and GPIIIa were isolated and purified using lentil lectin affinity chromatography and electrophoretic elution from SDS-PAGE gels (13) . a2-Plasmin inhibitor purified by the method of Wiman (14) , plasminogen isolated from plasma by lysine affinity chromatography (15) and gel filtration chromatography, and antithrombin III were kindly provided by Dr. Peter Harpel, Cornell University Medical College. Factor VIII:AGN and fibronectin were isolated from human plasma (16, 17) . Purified human albumin and y-globulin were obtained from Behring Diagnostics, Inc., Woodbury, NY.
Antisera. Antisera to chromatographically pure peak 1 human fibrinogen, a2-plasmin inhibitor, and antithrombin III were kindly supplied by Dr. Peter Harpel. The antifibrinogen serum following two times absorption with insolubilized pooled human serum (18) failed to react by ELISA with purified human albumin, fibronectin, plasminogen, Factor VIII:AGN, or partially purified TSP mixture. Antisera to purified TSP were raised in rabbits (16) . The anti-TSP serum was absorbed two times with insolubilized human fibrinogen and failed to react by ELISA with purified human albumin, fibrinogen, fibronectin, plasminogen, and Factor VIII:AGN. Monospecific anti-Factor VIII:AGN and antiplatelet GPIIb and GPIIIa and antifibronectin were prepared as described (13, 16, 17) . Antialbumin was obtained from Behring Diagnostics. 7-Globulin fractions of the various antisera were prepared as described (16) .
ELISA. The performance of the assay was essentially as described by Voller et al. (19) . Microtitration (20) as previously described (21) was added for 3-h incubation at 4°C. The wells were emptied, the wash step repeated, and 0.2 ml of the substrate p-nitrophenyl phosphate (1 mg/ml in 10% diethanolamine buffer, pH 9.8) added. The color development was followed at 15-min intervals by repeated readings at 405 nm in a Titertek multiscan photometer. Color development with time was plotted and the best-fit curve was calculated by linear regression analysis. The formation of the fibrinogen-TSP complex was expressed as the enzymatic activity of the bound alkaline phosphatase (AA405 min-').
Determination of protein-coating efficiency on microtitration plate. Purified human TSP, fibrinogen, fibronectin, plasminogen and Factor VIII:AGN were labeled with 1251I using the modified chloramine-T method (12) . Microtitration plates were coated in duplicate with 0.2-ml portions of the labeled proteins at increasing concentrations in the bicarbonate-coating buffer at 4°C overnight as described above. After washing three times with Tris-Tween buffer, each well was cut out, radioactivity of the coated protein counted, and the coating efficiency for each protein determined. The saturating amounts of proteins that could be coated per well were 0.92 pmol (TSP), 0.7 pmol (fibrinogen), 3.4 pmol (plasminogen), 1 1:1,500 dilution was added. The amount of antibody bound to the adsorbed fibrinogen was monitored by incubation with alkaline phosphatase-labeled protein A. The resulting hydrolysis of the substrate p-nitrophenyl phosphate was linear with the concentration of fibrinogen added to the well up to 300 ng/ml. Using 1251-labeled fibrinogen, the actual amount of fibrinogen bound to the plastic well was determined at each concentration of protein added and this was correlated with the color generated in the ELISA (Fig.  2) . It should be noted that no differences in reactivity with specific antibody were noted when nonlabeled fibrinogen was compared with '25I-labeled fibrinogen.
Complex formation of fibrinogen with TSP. Fibrinogen attached and formed a complex with the TSP adsorbed to the wells of the plastic microtitration plate. The extent of the complex formation was determined by the enzymatic activity of the bound alkaline phosphatase coupled to protein A (Table I) . No significant enhancement of the complex formation was noted in the presence of 0.5 mM Ca+.
To ascertain the possibility that the observed fibrinogen binding property of TSP might be due to a trace of contaminating protein undetected in SDS-PAGE by Coomassie Blue (Fig. 1) , binding studies were performed by adding fluid-phase '251-labeled TSP to fibrinogen-coated wells. The bound radiolabeled proteins were solubilized with 2% SDS, reduced with 2% dithiothreitol, and analyzed by SDS-PAGE. The solubilized, bound protein contained a single radioactive peak of 185,000 Mr, which coincided with the major radioactive peak in the reduced pure TSP sample. (Table  II) . Similarly, no inhibition of fibrinogen complex formation with TSP was detected in the presence of fluidphase y-globulin, Factor VIII:AGN, or fibronectin (data not shown).
The specificity of the fibrinogen interaction with adsorbed TSP was studied further by incubating fluidphase fibrinogen in separate experiments with adsorbed Factor VIII:AGN, fibronectin, or plasminogen (Table III) . Minimal complex formation was detected with purified fibronectin and purified plasminogen. These latter two protein preparations did not contain TSP using anti-TSP in an ELISA assay.
The specificity of the interaction of adsorbed TSP with fibrinogen was also studied by incubating various fluid-phase proteins in separate experiments with adsorbed TSP (Table IV) . Fibronectin, which was fibrinogen free by ELISA, showed small but reproducible complex formation.
Stoichiometry of the fibrinogen-TSP complex formation. Saturation of the binding or complexing of fibrinogen to adsorbed TSP was determined by plotting the specific binding (total minus nonspecific) of incremental amount of fibrinogen to a fixed amount of adsorbed TSP (Fig. 3) . The amount of fibrinogen bound at each concentration was determined from the color generated in the ELISA using the fibrinogen standard curve (Fig. 2) . A Scatchard plot analysis of these data revealed an apparent dissociation constant (Kd) for fibrinogen of 3.4 nM and the maximum amount of fibrinogen bound per well was determined to be 12.7 ng (Fig. 3, inset) . Using radiolabeled TSP, the coating efficiency of TSP at 2 ug/ml was 34.4%, corresponding to 137.7 ng of TSP bound per well. Assum- 18 h at 4°C. After washing, fibrinogen (4 lAg/ml) was added alone or in the presence of TSP (4 Mg/ml) or albumin (4 Mg/ml).
The remaining steps were carried out as described in Table I . The proteins (4 Ag/ml) in coating buffer were applied separately to plastic wells for 18 h at 4°C. After washing, fibrinogen (4 ug/ ml) in Tris-Tween buffer was added for 24 h at 4°C. The remaining steps were carried out as described in Table I. ing a M, of 420,000 for TSP (22) , and M, of 330,000
for fibrinogen, the data suggest a stoichiometric relationship of TSP to fibrinogen of 9:1. Effect of amino sugars and amino acids on the fibrinogen-TSP complex formation. Previous studies have suggested that specific amino sugars such as glucosamine and mannosamine and amino acids, such as arginine, block platelet lectin activity (2, 10) , and interfere with platelet fibrinogen binding (23) . Glucosamine, mannosamine, and arginine partially inhibited fibrinogen complex formation with TSP (Table V) . In contrast, N-acetyl glucosamine, N-acetyl mannosamine, and glycine had no effect. This same spectrum of inhibitory activity was observed on fibronectin-TSP complex formation (data not shown).
Influence on fibrinogen-TSP complex formation by platelet GPIIb and GPIIIa. Previous studies have demonstrated that isolated platelet membrane GPIIb and GPIIIa form a calcium-dependent complex with fibrinogen (21) . The GPIIb-GPIIIa macromolecular [Fibrinogen] (pg/ml) FIGURE 3 Saturation of fibrinogen complex formation with adsorbed TSP as measured by the ELISA. TSP (2 Ag/ml) in coating buffer was applied to the plastic wells for 18 h at 4°C. After washing, varying amounts of fibrinogen in Tris-Tween buffer were added alone or in the presence of TSP (32 ,ug/ml) for 24 h at 4°C. The remaining steps were carried out as described in Table I . The extent of specific fibrinogen complex formation with adsorbed TSP (total minus nonspecific) was plotted as a function of increasing fibrinogen concentration. Inset: Scatchard plot of fibrinogen binding to adsorbed TSP from Fig. 3 . y, -0.0044x + 0.055; r, -0.815.
complex on the platelet surface may act as a fibrinogen binding site (24) . Binding studies were performed using the ELISA system to determine whether GPIIb and GPIIIa in the fluid phase competed with adsorbed TSP for fibrinogen complex formation. No inhibition of fibrinogen complex formation with TSP was noted in the presence of the platelet membrane GP (Table VI) (2) and TSP lectin activity (10) . It is of interest that the same amino sugars and amino acids also block thrombin-induced platelet aggregation (2) . patients with the gray platelet syndrome, a selective deficiency of a-granules, do not aggregate normally upon stimulation with thrombin (8) . These observations suggest that the formation of the fibrinogen-TSP complex on the platelet surface may play an important role in thrombin-induced platelet aggregation. It is of interest that the adsorbed TSP also formed a complex with fibrinogen-free fibronectin. The extent of fibronectin-TSP complex formation was significantly less than the fibrinogen-TSP complex formation. Recent studies have shown that fibronectin binds to thrombin-stimulated platelets (25) . It is possible that TSP secreted from the a-granules and bound to the platelet membrane serves as the site of fibronectin attachment; however, the role of fibronectin in platelet membrane function remains to be determined.
The stoichiometry of the fibrinogen-TSP interaction on the plastic microtitration plates suggests that one fibrinogen molecule was bound per nine adsorbed TSP molecules, with a KD of 3.4 nM. The stoichiometric relationship of the interacting constituents must be interpreted with some caution. Thus, these studies utilize a plastic surface with coated TSP molecules. It is highly probable that the adsorbed TSP molecules are oriented in a random manner with significant steric restriction. Thus, only a fraction of the adsorbed TSP may be functionally capable of binding to the soluble fibrinogen. These considerations make it likely that the 9:1 stoichiometry is an overestimation. More physiologically relevant surfaces, such as liposomes, may be more appropriate for defining the stoichiometry and affinity of this complex formation.
What is the relationship of fibrinogen complex formation with membrane-bound TSP to normal aggregation, which appears to be dependent on fibrinogen binding? Previous data strongly suggest that platelet GPIIb and GPIIIa are major components of the platelet plasma membrane that are important in aggregation. These GP are missing or markedly diminished in Glanzmann's thrombasthenia, a hereditary bleeding disorder characterized by defective platelet aggregation (25) . ADP, epinephrine, and thrombin-induced fibrinogen binding in normal platelets correlates with For experiments with TSP-coated wells, TSP (4 gg/rnl) in coating buffer was applied to the plastic wells for 18 h at 4°C. After washing, fibrinogen (4 tg/ml) in 0.5 mM Ca" Tris-Tween buffer was added for 24 h at 4°C, in the presence or absence of a mixture of GPIIb-GPIIIa (4 sg/ml). For experiments with fibrinogen-coated wells, fibrinogen (4 jg/ml) was coated in a similar manner, followed by the addition of TSP (4 Mg/ml) and/or GPIIb-GPIIIa (4.ug/ml) in 1 mM Ca++ Tris-Tween buffer. The remaining steps were carried out as described in Table I . Anti-GPIIb and anti-GPIIIa were used in 1:100 dilution and anti-TSP in 1:1,000 dilution.
Fibrinogen-Thrombospondin Complex Formation aggregation, while nonaggregating thrombasthenic platelets do not bind fibrinogen (12, 27, 28) . We have previously demonstrated that clustering of GPIIb and GPIIIa complexes occur in the thrombin-stimulated platelet membrane (29) , and that GPIIb-GPIIIa complexes bind fibrinogen (21) . In this study, GPIIb and GPIIIa mixtures did not inhibit complex formation of fibrinogen with TSP (Table VI) . This suggests that the binding sites of fibrinogen for TSP are different from the binding sites for the membrane GP. It is of interest that recent data suggest that there may be two different classes of fibrinogen receptors in normal human platelets (30, 31) . Our data raise the possibility that asymmetrical protein bridges form between aggregating platelets following thrombin stimulation. TSP released from a-granules fixed to the membrane of one cell may bind fibrinogen, which is bound to a GPIIbGPIIIa cluster on an adjacent cell. It remains to be determined whether symmetrical bridges may form under some circumstances with fibrinogen linking two TSP sites on different cells. The precise molecular interactions on the platelet membrane leading to aggregation remain to be fully clarified. The studies reported here support the hypothesis that the interaction of fibrinogen with TSP on the activated platelet surface may be an important step in the platelet aggregation process.
